TB, they are going for fast tracked approval, all preparations now aiming at rego trial. The FDA had already suggested that / urged them to go that way. Today's results are just confirming that pathway as outlined during the webinar. Wished IMU would do the presentation that way, just much easier to understand.
GLTA
CHM Price at posting:
4.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)